Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antimalarial drugs inhibit the replication of SARS-CoV-2: An in vitro evaluation
Mathieu Gendrot, Julien Andréani, Manon Boxberger, et al.
Travel Medicine and Infectious Disease (2020) Vol. 37, pp. 101873-101873
Open Access | Times Cited: 99

Showing 1-25 of 99 citing articles:

A human-airway-on-a-chip for the rapid identification of candidate antiviral therapeutics and prophylactics
Longlong Si, Haiqing Bai, Melissa Rodas, et al.
Nature Biomedical Engineering (2021) Vol. 5, Iss. 8, pp. 815-829
Open Access | Times Cited: 325
Low incidence of COVID-19 case severity and mortality in Africa; Could malaria co-infection provide the missing link?
Silas Acheampong Osei, Robert Peter Biney, Alberta Serwah Anning, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 67
Alkaloids as potential antivirals. A comprehensive review
Shah Faisal, Syed Badshah, Bibi Kubra, et al.
Natural Products and Bioprospecting (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 47
Efficacy and Safety of Antimalarial as Repurposing Drug for COVID-19 Following Retraction of Chloroquine and Hydroxychloroquine
Irma Rahayu Latarissa, Miski Aghnia Khairinisa, Ghina Nadhifah Iftinan, et al.
Clinical Pharmacology Advances and Applications (2025) Vol. Volume 17, pp. 1-11
Open Access | Times Cited: 1
In Vitro Antiviral Activity of Doxycycline against SARS-CoV-2
Mathieu Gendrot, Julien Andréani, Priscilla Jardot, et al.
Molecules (2020) Vol. 25, Iss. 21, pp. 5064-5064
Open Access | Times Cited: 87
An overview of the anti-SARS-CoV-2 properties of Artemisia annua, its antiviral action, protein-associated mechanisms, and repurposing for COVID-19 treatment
Andréa D. Fuzimoto
Journal of Integrative Medicine (2021) Vol. 19, Iss. 5, pp. 375-388
Open Access | Times Cited: 64
Quinine Inhibits Infection of Human Cell Lines with SARS-CoV-2
Maximilian Große, Natalia Ruétalo, Mirjam Layer, et al.
Viruses (2021) Vol. 13, Iss. 4, pp. 647-647
Open Access | Times Cited: 51
Alkaloids as Potential Phytochemicals against SARS-CoV-2: Approaches to the Associated Pivotal Mechanisms
Mohammad Bagher Majnooni, Sajad Fakhri, Gholamreza Bahrami, et al.
Evidence-based Complementary and Alternative Medicine (2021) Vol. 2021, pp. 1-21
Open Access | Times Cited: 46
Identification of multipotent drugs for COVID-19 therapeutics with the evaluation of their SARS-CoV2 inhibitory activity
Sugandh Kumar, Bharati Singh, Pratima Kumari, et al.
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 1998-2017
Open Access | Times Cited: 43
Artesunate—multiple pharmacological effects beyond treating malaria
Yuan‐Shiun Chang, Tong Lyu, Xiaojie Luan, et al.
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117292-117292
Closed Access
IMU-838, a Developmental DHODH Inhibitor in Phase II for Autoimmune Disease, Shows Anti-SARS-CoV-2 and Broad-Spectrum Antiviral Efficacy In Vitro
Friedrich Hahn, Christina Wangen, Sigrun Häge, et al.
Viruses (2020) Vol. 12, Iss. 12, pp. 1394-1394
Open Access | Times Cited: 48
In silico study of some selective phytochemicals against a hypothetical SARS-CoV-2 spike RBD using molecular docking tools
Anish Nag, Subhabrata Paul, Ritesh Banerjee, et al.
Computers in Biology and Medicine (2021) Vol. 137, pp. 104818-104818
Open Access | Times Cited: 39
Predicting Potential SARS-COV-2 Drugs—In Depth Drug Database Screening Using Deep Neural Network Framework SSnet, Classical Virtual Screening and Docking
Nischal Karki, Niraj Verma, Francesco Trozzi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1573-1573
Open Access | Times Cited: 36
A detailed review of the outbreak of COVID-19
Kabita Das, M. Shivapriya Pingali, Biswaranjan Paital, et al.
Frontiers in Bioscience-Landmark (2021) Vol. 26, Iss. 6, pp. 149-149
Open Access | Times Cited: 34
Broad spectrum anti-coronavirus activity of a series of anti-malaria quinoline analogues
Leentje Persoons, Evelien Vanderlinden, Laura Vangeel, et al.
Antiviral Research (2021) Vol. 193, pp. 105127-105127
Open Access | Times Cited: 34
Drug Repurposing Against SARS-CoV-1, SARS-CoV-2 and MERS-CoV
Sarah Aherfi, Bruno Pradines, Christian Devaux, et al.
Future Microbiology (2021) Vol. 16, Iss. 17, pp. 1341-1370
Open Access | Times Cited: 34
Mefloquine, a Potent Anti-severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Drug as an Entry Inhibitor in vitro
Kaho Shionoya, Masako Yamasaki, Shoya Iwanami, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 33
Reactivation of Epstein–Barr virus (<i>Herpesviridae: Lymphocryptovirus</i>, HHV-4) infection during COVID-19: epidemiological features
T. V. Solomay, Т. А. Семененко, Filatov Nn, et al.
Problems of Virology (2021) Vol. 66, Iss. 2, pp. 152-161
Open Access | Times Cited: 33
Drug Repurposing and Polypharmacology to Fight SARS-CoV-2 Through Inhibition of the Main Protease
Luca Pinzi, Annachiara Tinivella, Fabiana Caporuscio, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 32
SARS-CoV-2 omicron variants are susceptible in vitro to Artemisia annua hot water extracts
Manoj S. Nair, Yiming Huang, M. Wang, et al.
Journal of Ethnopharmacology (2023) Vol. 308, pp. 116291-116291
Open Access | Times Cited: 12
Current Updates on Naturally Occurring Compounds Recognizing SARS-CoV-2 Druggable Targets
Isabella Romeo, Francesco Mesiti, Antonio Lupia, et al.
Molecules (2021) Vol. 26, Iss. 3, pp. 632-632
Open Access | Times Cited: 28
Antiviral Activity of Umifenovir In Vitro against a Broad Spectrum of Coronaviruses, Including the Novel SARS-CoV-2 Virus
Irina A. Leneva, Н. П. Карташова, А. А. Поромов, et al.
Viruses (2021) Vol. 13, Iss. 8, pp. 1665-1665
Open Access | Times Cited: 27
The naturally‐derived alkaloids as a potential treatment for COVID‐19: A scoping review
Bárbara Longhini Gonzalez, Natalia Castelhano de Oliveira, Mariane Roberta Ritter, et al.
Phytotherapy Research (2022) Vol. 36, Iss. 7, pp. 2686-2709
Open Access | Times Cited: 20
RETRACTED: Artemisia Extracts and Artemisinin-Based Antimalarials for COVID-19 Management: Could These Be Effective Antivirals for COVID-19 Treatment?
Pawan K. Agrawal, Chandan Agrawal, Gerald Blunden
Molecules (2022) Vol. 27, Iss. 12, pp. 3828-3828
Open Access | Times Cited: 18
CFTR Inhibitors Display In Vitro Antiviral Activity against SARS-CoV-2
Anna Lagni, Virginia Lotti, Erica Diani, et al.
Cells (2023) Vol. 12, Iss. 5, pp. 776-776
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top